ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

No reported Capital Expenditures figures are available to summarize.

Capital Expenditures history

Currency unavailable · from the cash flow

No Capital Expenditures data reported for this period type.

Capital Expenditures vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Capital Expenditures for ADRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MGTXMeiraGTx Holdings plcLTM Mar 2026$10.62M USD+113.0%-56.0%13.3%
PRMEPrime Medicine, Inc.LTM Mar 2026$2.32M USD-68.6%-34.5%57.6%
RNAAtrium Therapeutics, Inc.FY2025$1.45M USD——7.8%
WVEWave Life Sciences Ltd.LTM Mar 2026$981.99K USD+43.1%-19.2%1.4%
PRQRProQR Therapeutics N.V.LTM Mar 2026€955.79K EUR+5.0%+11.4%7.1%
STOKStoke Therapeutics, Inc.LTM Mar 2026$871K USD+153.9%-44.7%2.7%
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026$318.66K USD-41.5%-69.0%0.7%
SLNSilence Therapeutics plcLTM Mar 2026$106K USD—-53.4%11.5%
BNTCBenitec Biopharma Inc.LTM Mar 2026$27.51K USD+48.2%+11.5%—
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —+43.1%-39.6%7.4%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.